Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Biotech
Novartis pays Legend $100M to give CAR-Ts the T-Charge treatment
Novartis will give a solid-tumor-focused therapy the T-Charge treatment, paying $100 million upfront to Legend for a selection of CAR-T candidates.
James Waldron
Nov 13, 2023 10:00am
Celldex laces up next to Big Pharmas with chronic hive drug
Nov 6, 2023 10:17am
Novartis' $3.2B Chinook bet takes flight as phase 3 hits goal
Oct 30, 2023 8:16am
Novartis knows what's ahead as peers enter radiopharmaceuticals
Oct 24, 2023 7:00am
Google DeepMind vet to join GSK—Chutes & Ladders
Oct 20, 2023 9:30am
Novartis cuts depression study, erasing Cadent buy from pipeline
Oct 10, 2023 10:52am
